Liu Shih-Feng, Chin Chien-Hung, Tseng Ching-Wang, Chen Yung-Che, Kuo Ho-Chang
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
Medicina (Kaunas). 2021 Oct 15;57(10):1110. doi: 10.3390/medicina57101110.
Exertional desaturation (ED) is often overlooked in chronic obstructive pulmonary disease (COPD). We aim to investigate the impact of ED on mortality and the predictors of ED in COPD. A cohort of COPD patients with clinically stable, widely ranging severities were enrolled. ED is defined as oxyhemoglobin saturation by pulse oximetry (SpO2) < 90% or a drop of ΔSpO2 ≥ 4% during a six-minute walk test (6MWT). Cox regression analysis is used to estimate the hazard ratio (HR) for three-year mortality. A total of 113 patients were studied, including ED ( = 34) and non-ED ( = 79) groups. FVC (% of predicted value), FEV1/FVC (%), FEV1 (% of predicted value), DLCO (%), maximal inspiratory pressure, SpO2 during the 6MWT, GOLD stage, and COPD severity were significantly different between the ED and non-ED groups in univariate analysis. Low minimal SpO2 ( < 0.001) and high maximal heart rate ( = 0.04) during the 6MWT were significantly related to ED in multivariate analysis. After adjusting for age, gender, body mass index, 6MWD, FEV1, mMRC, GOLD staging, exacerbation, hs-CRP, and fibrinogen, the mortality rate of the ED group was higher than that of the non-ED group ( = 0.012; HR = 4.12; 95% CI 1.37-12.39). For deaths, the average survival time of ED was shorter than that of the non-ED group (856.4 days vs. 933.8 days, = 0.033). : ED has higher mortality than non-ED in COPD. COPD should be assessed for ED, especially in patients with low minimal SpO2 and high maximal HR during the 6MWT.
运动性低氧血症(ED)在慢性阻塞性肺疾病(COPD)中常被忽视。我们旨在研究ED对COPD患者死亡率的影响以及ED的预测因素。纳入了一组病情临床稳定、严重程度范围广泛的COPD患者。ED定义为在六分钟步行试验(6MWT)期间,经脉搏血氧饱和度测定的氧合血红蛋白饱和度(SpO2)<90%或SpO2下降Δ≥4%。采用Cox回归分析估计三年死亡率的风险比(HR)。共研究了113例患者,包括ED组(n = 34)和非ED组(n = 79)。在单因素分析中,ED组和非ED组之间的用力肺活量(预测值百分比)、第一秒用力呼气容积/用力肺活量(%)、第一秒用力呼气容积(预测值百分比)、一氧化碳弥散量(%)、最大吸气压力、6MWT期间的SpO2、慢性阻塞性肺疾病全球倡议(GOLD)分级和COPD严重程度存在显著差异。在多因素分析中,6MWT期间的最低SpO2低(P<0.001)和最大心率高(P = 0.04)与ED显著相关。在调整年龄、性别、体重指数、6分钟步行距离、第一秒用力呼气容积、改良英国医学研究委员会(mMRC)呼吸困难量表、GOLD分级、急性加重、高敏C反应蛋白和纤维蛋白原后,ED组的死亡率高于非ED组(P = 0.012;HR = 4.12;95%置信区间1.37 - 12.39)。对于死亡患者,ED患者的平均生存时间短于非ED组(856.4天对933.8天,P = 0.033)。结论:在COPD中,ED患者的死亡率高于非ED患者。应对COPD患者进行ED评估,尤其是在6MWT期间最低SpO2低和最大心率高的患者中。